Acquisition Opportunity The Dunn Group is being acquired by SAI MedPartners, creating a potential opportunity to engage the consolidating entity with cross-selling of competitive intelligence services to expand market coverage and integrate TDG capabilities into broader life sciences offerings.

Target Market Fit With TDG operating in pharmaceuticals, biotech, diagnostics and medical devices, there is a clear path to upsell advanced market intelligence, benchmarking, and data analytics services to life sciences manufacturers undergoing digital transformation and regulatory changes.

Revenue Growth Potential TDG’s reported revenue of 10–25 million positions it as a mid-market player ideal for scalable consulting and SaaS data services that can be introduced as productized intelligence subscriptions or tiered analytics offerings to accelerate client ROI.

Tech Stack Leverage TDG relies on cloud and CMS platforms (Google Cloud CDN, Google Cloud, Wix, WordPress) and standard security/monitoring tools (Sentry, reCAPTCHA) offering opportunities to offer modernization services, data integration, and enhanced security/compliance packages for clients in regulated life sciences sectors.

Competitive Positioning As a global leader in life sciences business intelligence, TDG can be positioned as a strategic partner for large enterprises and mid-size firms seeking competitive intelligence, market trends, and decision support, with expansion opportunities through SAI MedPartners’ network and broader analytics capabilities.